Fort Dodge Animal Health recently received USDA approval to release the following abstract regarding the West Nile virus vaccine and its efficacy. More information on the topic was presented in today’s sessions at the World Organisation for Animal Health (Office International des Epizooties–OIE) meeting “Vaccines for OIE list A and Emerging Diseases” in Ames, Iowa. This study was done on normal healthy horses, isolated from natural exposure. Watch the web site tomorrow for more information on this story from the study’s authors.

For more information on West Nile virus, visit https://thehorse.com/wnv.

Equine Vaccine for West Nile Virus
by T. Ng, D. Hathaway, N. Jennings, Y.W. Chiang, H.J. Chu. Biological Research and Development, Fort Dodge Animal Health

The West Nile virus (WNV) was first isolated and identified from birds, mosquitoes, and mammals including horses in three states of the northeastern United States in 1999. Since then, WNV infection has been spread to southeastern and Midwestern states. In order to meet the urgent need of controlling the WNV infection in equine population, we have developed a killed WNV vaccine. A dose titration study in horses was first conducted to evaluate serum neutralization antibody responses against WNV in horses

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

SIGN UP

Already have an account?
Login and continue reading.